Page last updated: 2024-10-22

anthralin and Leukocytosis

anthralin has been researched along with Leukocytosis in 1 studies

Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.
anthralin : An anthracene compound derived by the substitution of -OH groups for hydrogen at C-1 and C-8, and with an oxo group at C-9.

Leukocytosis: A transient increase in the number of leukocytes in a body fluid.

Research Excerpts

ExcerptRelevanceReference
"Our findings suggest that dithranol treatment of a psoriasis plaque is associated with a decrease in oxygen radical generating capacity in vivo."1.29Effects of dithranol on neutrophil superoxide generation in patients with psoriasis. ( Burton, JL; Donnell, VO; Kavanagh, GM, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kavanagh, GM1
Burton, JL1
Donnell, VO1

Other Studies

1 other study available for anthralin and Leukocytosis

ArticleYear
Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
    The British journal of dermatology, 1996, Volume: 134, Issue:2

    Topics: Administration, Topical; Anthralin; Anti-Inflammatory Agents; Cell Culture Techniques; Female; Human

1996